James A. Liubicich

FDA investigator · also recorded as James A. Liubicich-

Appears on 13 documents from 2013 to 2015, mostly at sites in New York. Most often cites design and construction features (21 CFR 211.42).

13
Documents on file
9.3
Observations per 483
2013
First seen
2015
Most recent

What they cite most

From 111 observations

Activity by year

2013: 5, 2014: 5, 2015: 3

Where

New York 11 · New Jersey 2

Is James A. Liubicich coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Pine PharmaceuticalsOct 23, 2015 · Tonawanda, New York
483 Americare Compounding, LLCJun 22, 2015 · Garden City South, New York
483 Master Pharm LLCMay 6, 2015 · Richmond Hill, New York
Response BioScrip Pharmacy (NY), Inc.Oct 10, 2014 · Jamaica, New York
483 BioScrip Pharmacy (NY), Inc.Sep 19, 2014 · Lake Success, New York
483 Alexander Infusion, LLC dba Avanti Health Care ServicesJul 9, 2014 · New Hyde Park, New York
483 Infusion Options, Inc.Apr 23, 2014 · Brooklyn, New York

About this profile

What does James A. Liubicich inspect?

James A. Liubicich appears on 13 documents on file covering 10 sites, mostly in New York.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.166.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for James A. Liubicich is dated Oct 23, 2015.